PRKAA1 and neoplasm: Its anti-tumor effects could be directly linked to this effect on energetic status, especially on adenosine monophosphate kinase (AMPK) activation, through the inhibition of mitochondrial respiratory chain complex I, resulting in ATP synthesis reduction [16].